SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034530
Filing Date
2024-11-12
Accepted
2024-11-12 16:01:45
Documents
52
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20240930_10q.htm   iXBRL 10-Q 695368
2 EXHIBIT 31.1 ex_744201.htm EX-31.1 14217
3 EXHIBIT 31.2 ex_744202.htm EX-31.2 14150
4 EXHIBIT 32.1 ex_744203.htm EX-32.1 6464
5 EXHIBIT 32.2 ex_744204.htm EX-32.2 6889
  Complete submission text file 0001437749-24-034530.txt   3269229

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA govx-20240930.xsd EX-101.SCH 34958
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20240930_def.xml EX-101.DEF 228380
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20240930_lab.xml EX-101.LAB 201054
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20240930_pre.xml EX-101.PRE 247432
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20240930_cal.xml EX-101.CAL 26771
55 EXTRACTED XBRL INSTANCE DOCUMENT govx20240930_10q_htm.xml XML 318054
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 241447777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)